The research showed that a protein called KIM-1, which is elevated in the blood of some RCC patients at the time of diagnosis, could also be used as a tool to predict onset of the disease up to five years prior to diagnosis.
Lead investigator Rupal Bhatt (Harvard Medical School) says the study showed a significant association between plasma KIM-1 concentrations and the risk of renal cell carcinoma.
